The impact of the COVID-19 pandemic on addressing common barriers to pharmacy-based point-of-care testing.
Expert Rev Mol Diagn
; 21(8): 751-755, 2021 08.
Article
in English
| MEDLINE | ID: covidwho-1269466
ABSTRACT
Introduction:
Pharmacy-based point-of-care testing has long had the potential to improve patient access to timely care, but adoption has been slowed by financial and regulatory barriers. The COVID-19 pandemic reduced or temporarily eliminated many of the barriers to pharmacy-based testing. This review examines how the changes brought on by may impact pharmacy-based testing after the pandemic.Areas covered This review searched peer-reviewed, lay, and regulatory literature to explore the implementation of pharmacy-based COVID-19 testing. This includes a review of regulatory and financial changes that removed barriers to testing. Additionally, it reviews the literature related to the growth of pharmacy-based testing.Expert opinion It is clear that the COVID-19 pandemic created an awareness and opportunity for pharmacy-based point-of-care testing. The changes made in response to the pandemic have the potential to increase the role of pharmacy-based testing, but additional regulatory changes and wider pharmacy adoption are still needed to maximize the value of such services.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Community Pharmacy Services
/
Point-of-Care Testing
/
COVID-19 Testing
Type of study:
Diagnostic study
/
Experimental Studies
/
Observational study
Limits:
Humans
Language:
English
Journal:
Expert Rev Mol Diagn
Journal subject:
Molecular Biology
Year:
2021
Document Type:
Article
Affiliation country:
14737159.2021.1944105
Similar
MEDLINE
...
LILACS
LIS